SPI Infoamtion

本レポートに関しましてはExecutive Summaryのみ 195USD での販売も行っておりますので、 お問い合わせ下さい。

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY
1.1 TOTAL ORTHOPEDIC BIOMATERIALS MARKET
1.2 GROWTH FACTOR AND BONE GRAFT SUBSTITUTE MARKET
1.3 MACHINED BONE ALLOGRAFT MARKET
1.4 HYALURONIC ACID VISCOSUPPLEMENTATION MARKET
1.5 RESORBABLE FIXATION DEVICE MARKET
1.6 TENDON GRAFT MARKET
1.7 CARTILAGE REPAIR MARKET
1.8 PLATELET AND BONE MARROW CONCENTRATION MARKET
1.9 STEM CELL MARKET
1.10 LEADING COMPETITORS

RESEARCH METHODOLOGY
2.1 RESEARCH SCOPE
2.2 IDATA’S 9-STEP METHODOLOGY
2.2.1 Step 1: Project Initiation & Team Selection
2.2.2 Step 2: Prepare Data Systems and Perform Secondary Research
2.2.3 Step 3: Preparation for Interviews & Questionnaire Design
2.2.4 Step 4: Performing Primary Research
2.2.5 Step 5: Research Analysis: Establishing Baseline Estimates
2.2.6 Step 6: Market Forecast and Analysis
2.2.7 Step 7: Identify Strategic Opportunities
2.2.8 Step 8: Final Review and Market Release
2.2.9 Step 9: Customer Feedback and Market Monitoring

OVERVIEW OF ORTHOPEDIC BIOMATERIALS
3.1 INTRODUCTION
3.1.1 Growth Factors
3.1.2 Bone Graft Substitutes
3.1.3 Machined Bone Allografts
3.1.4 Hyaluronic Acid Viscosupplementation
3.1.5 Resorbable Fixation Devices
3.1.6 Tendon Grafts
3.1.7 Cartilage Repair
3.1.8 Platelet and Bone Marrow Concentration
3.1.9 Orthopedic Stem Cell Therapy
3.2 MARKET ANALYSIS AND FORECAST
3.3 MARKET DRIVERS AND LIMITERS
3.3.1 Market Drivers
3.3.2 Market Limiters
3.4 COMPETITIVE ANALYSIS
3.4.1 Market Concentration
3.5 MERGERS AND ACQUISITIONS

GROWTH FACTOR MARKET
4.1 INTRODUCTION
4.1.1 Overview
4.1.2 BMP-2 (Medtronic)
4.1.3 BMP-7 (Stryker)
4.1.4 Potential Complications
4.1.5 Reimbursement
4.1.6 Future Indications
4.2 MARKET ANALYSIS AND FORECAST
4.3 MARKET DRIVERS AND LIMITERS
4.3.1 Market Drivers
4.3.2 Market Limiters
4.4 COMPETITIVE ANALYSIS
4.4.1 Leading Competitors
4.4.2 Potential Competitors

BONE GRAFT SUBSTITUTE MARKET
5.1 INTRODUCTION
5.2 MARKET SEGMENTATION
5.2.1 Indications
5.2.2 Materials
5.3 MARKET ANALYSIS AND FORECAST
5.4 BONE GRAFT SUBSTITUTE MARKET BY INDICATION
5.4.1 Thoracolumbar Spinal Fixation Procedures
5.4.2 Thoracolumbar Spinal Bone Graft Substitute Market
5.4.3 Cervical Spinal Bone Graft Substitute Market
5.4.4 Trauma Bone Graft Substitute Market
5.4.5 Hip Bone Graft Substitute Market
5.4.6 Knee Bone Graft Substitute Market
5.4.7 Craniomaxillofacial Bone Graft Substitute Market
5.5 BONE GRAFT SUBSTITUTE MARKET BY MATERIAL
5.5.1 Autograft
5.5.2 Total Standard Allograft
5.5.3 Total DBM Market
5.5.4 Total Synthetic Bone Graft Substitute Market
5.6 MARKET DRIVERS AND LIMITERS
5.6.1 Market Drivers
5.6.2 Market Limiters
5.7 COMPETITIVE ANALYSIS
5.7.1 Total Bone Graft Substitute Market
5.7.2 Standard Allograft Market
5.7.3 DBM Market
5.7.4 Synthetic Bone Graft Substitute Market
5.7.5 Autograft Market

MACHINED BONE ALLOGRAFT MARKET
6.1 INTRODUCTION
6.1.1 Approaches
6.1.2 Interbody Device Procedure Percentages by Material
6.2 MARKET FORECAST AND ANALYSIS
6.2.1 ALIF Approach
6.2.2 PLIF Approach
6.2.3 TLIF Approach
6.2.4 Cervical Machined Bone Allografts
6.3 MARKET DRIVERS AND LIMITERS
6.3.1 Market Drivers
6.3.2 Market Limiters
6.4 COMPETITIVE ANALYSIS

HYALURONIC ACID VISCOSUPPLEMENTATION MARKET
7.1 INTRODUCTION
7.1.1 Benefits of Viscosupplementation
7.1.2 Synovial Fluid
7.1.3 Three-Injection Cycle Products
7.1.4 Five-Injection Cycle Products
7.1.5 Single-Injection Cycle Products
7.1.6 Reimbursement
7.2 MARKET ANALYSIS AND FORECAST
7.2.1 Three-Injection Cycle
7.2.2 Five-Injection Cycle Viscosupplementation Market
7.2.3 Single-Injection Cycle Viscosupplementation Market
7.3 MARKET DRIVERS AND LIMITERS
7.3.1 Market Drivers
7.3.2 Market Limiters
7.4 COMPETITIVE ANALYSIS

RESORBABLE FIXATION DEVICE MARKET
8.1 INTRODUCTION
8.1.1 Materials
8.1.2 Disadvantages Compared to Metal Fixation
8.1.3 Indications and Product Descriptions
8.2 MARKET ANALYSIS AND FORECAST
8.2.1 Total Resorbable Fixation Market
8.2.2 Shoulder Resorbable Fixation Market
8.2.3 Knee Resorbable Fixation Market
8.2.4 Meniscal Resorbable Fixation Market
8.3 MARKET DRIVERS AND LIMITERS
8.3.1 Market Drivers
8.3.2 Market Limiters
8.4 COMPETITIVE ANALYSIS
8.4.1 Leading Competitors
8.4.2 Other Notable Competitors

TENDON GRAFT MARKET
9.1 INTRODUCTION
9.1.1 ACL/PCL Reconstruction Procedures
9.1.2 Bone-Patellar Tendon-Bone (BTB) Graft, ACL/PCL Surgery
9.1.3 Allograft Tendons
9.1.4 Popularity of the Anterior Tibialis Autograft
9.1.5 Ligament and Tendon Synthetic Grafts
9.1.6 Ligament and Tendon Xenografts
9.2 MARKET FORECAST AND ANALYSIS
9.2.1 Total Tendon Graft Market
9.2.2 Analysis of Tendon Units Procured per Donor
9.3 MARKET DRIVERS AND LIMITERS
9.3.1 Market Drivers
9.3.2 Market Limiters
9.4 COMPETITIVE ANALYSIS

CARTILAGE REPAIR MARKET
10.1 INTRODUCTION
10.1.1 Methods for Cartilage Repair
10.2 MARKET ANALYSIS AND FORECAST
10.2.1 Cartilage Autograft Procedures
10.2.2 Total Cartilage Repair Market
10.2.3 Autologous Chondrocyte Implantation Market
10.2.4 Osteochondral Allograft Market
10.2.5 Meniscal Graft Market
10.3 MARKET DRIVERS AND LIMITERS
10.3.1 Market Drivers
10.3.2 Market Limiters
10.4 COMPETITIVE ANALYSIS
10.4.1 Leading Competitors
10.4.2 Emerging Competitors

PLATELET AND BONE MARROW CONCENTRATION MARKET
11.1 INTRODUCTION
11.1.1 Platelet Rich Plasma
11.1.2 Bone Marrow Aspirate
11.2 MARKET ANALYSIS AND FORECAST
11.2.1 Total Platelet and Bone Marrow Concentration Market
11.2.2 Spinal Platelet Concentration Market
11.2.3 Extremity and Sports Medicine Platelet Concentration Market
11.2.4 Bone Marrow Aspirate Concentration Market
11.3 MARKET DRIVERS AND LIMITERS
11.3.1 Market Drivers
11.3.2 Market Limiters
11.4 COMPETITIVE ANALYSIS
11.4.1 Leading Competitors
11.4.2 Other Competitors

ORTHOPEDIC STEM CELL MARKET
12.1 INTRODUCTION
12.2 MARKET OVERVIEW
12.2.1 Lineage
12.2.2 Legislation
12.2.3 Other Therapeutic Applications
12.3 MARKET ANALYSIS AND FORECAST
12.3.1 Lumbar Spine Stem Cell Market
12.3.2 Cervical Spine Stem Cell Market
12.4 MARKET DRIVERS AND LIMITERS
12.4.1 Market Drivers
12.4.2 Market Limiters
12.5 COMPETITIVE ANALYSIS
12.5.1 Leading Competitors
12.5.2 Potential Competitors

EMERGING TECHNOLOGIES
13.1 INTRODUCTION
13.1.1 Emerging Cartilage Repair Technologies
13.1.2 Emerging Bone Graft Substitute Technologies
13.1.3 Xenografts

ABBREVIATIONS

LIST OF FIGURES
EXECUTIVE SUMMARY
RESEARCH METHODOLOGY
OVERVIEW OF ORTHOPEDIC BIOMATERIALS
Figure 3-1: Total Orthopedic Biomaterials Market, U.S., 2006 -- 2016
Figure 3-2: Drivers and Limiters, Orthopedic Biomaterials Market, U.S., 2009
Figure 3-3: Leading Competitors, Orthopedic Biomaterials Market, U.S., 2009 (Part 1 of 2)
Figure 3-4: Leading Competitors, Orthopedic Biomaterials Market, U.S., 2009 (Part 2 of 2)
Figure 3-5: Market Concentration, Orthopedic Biomaterials Market, U.S., 2009
GROWTH FACTOR MARKET
Figure 4-1: Total Growth Factor Market, U.S., 2006 -- 2016
Figure 4-2: Drivers and Limiters, Growth Factor Market, U.S., 2009
Figure 4-3: Leading Competitors, Growth Factor Market, U.S., 2009
BONE GRAFT SUBSTITUTE MARKET
Figure 5-1: Total Bone Graft Substitute Market, U.S., 2006 -- 2016
Figure 5-2: Thoracolumbar Spinal Fixation Procedures Segmented by Indication, U.S., 2006 -- 2016
Figure 5-3: Degenerative Thoracolumbar Spinal Fixation Procedures Segmented by Levels Fused, U.S., 2006 -- 2016
Figure 5-4: Thoracolumbar Spinal Bone Graft Substitute Market, U.S., 2006 -- 2016
Figure 5-5: Cervical Spinal Bone Graft Substitute Market, U.S., 2006 -- 2016
Figure 5-6: Trauma Bone Graft Substitute Market, U.S., 2006 -- 2016
Figure 5-7: Hip Bone Graft Substitute Market, U.S., 2006 -- 2016
Figure 5-8: Knee Bone Graft Substitute Market, U.S., 2006 -- 2016
Figure 5-9: CMF Bone Graft Substitute Market, U.S., 2006 -- 2016
Figure 5-10: Spinal Bone Graft Substitute Procedures, U.S., 2006 -- 2016
Figure 5-11: Total Standard Allograft Market, U.S., 2006 -- 2016
Figure 5-12: Spinal Standard Allograft Market, U.S., 2006 -- 2016
Figure 5-13: Thoracolumbar Spinal Standard Allograft Market, U.S., 2006 -- 2016
Figure 5-14: Cervical Spinal Standard Allograft Market, U.S., 2006 -- 2016
Figure 5-15: Trauma, Reconstruction and CMF Standard Allograft Market, U.S., 2006 -- 2016
Figure 5-16: Trauma Standard Allograft Market, U.S., 2006 -- 2016
Figure 5-17: Hip Reconstruction Standard Allograft Market, U.S., 2006 -- 2016
Figure 5-18: Knee Reconstruction Standard Allograft Market, U.S., 2006 -- 2016
Figure 5-19: CMF Standard Allograft Market, U.S., 2006 -- 2016
Figure 5-20: Total DBM Market, U.S., 2006 -- 2016
Figure 5-21: Spinal DBM Market, U.S., 2006 -- 2016
Figure 5-22: Thoracolumbar Spinal DBM Market, U.S., 2006 -- 2016
Figure 5-23: Cervical Spinal DBM Market, U.S., 2006 -- 2016
Figure 5-24: Trauma, Reconstruction and CMF DBM Market, U.S., 2006 -- 2016
Figure 5-25: Trauma DBM Market, U.S., 2006 -- 2016
Figure 5-26: Hip Reconstruction DBM Market, U.S., 2006 -- 2016
Figure 5-27: Knee Reconstruction DBM Market, U.S., 2006 -- 2016
Figure 5-28: CMF DBM Market, U.S., 2006 -- 2016
Figure 5-29: Total Synthetic Bone Graft Substitute Market, U.S., 2006 -- 2016
Figure 5-30: Spinal Synthetic Bone Graft Substitute Market, U.S., 2006 -- 2016
Figure 5-31: Thoracolumbar Spinal Synthetic Bone Graft Substitute Market, U.S., 2006 -- 2016
Figure 5-32: Cervical Spinal Synthetic Bone Graft Market, U.S., 2006 -- 2016
Figure 5-33: Trauma, Reconstruction and CMF Synthetic Bone Graft Substitute Market, U.S., 2006 -- 2016
Figure 5-34: Trauma Synthetic Bone Graft Substitute Market, U.S., 2006 -- 2016
Figure 5-35: Hip Reconstruction Synthetic Bone Graft Substitute Market, U.S., 2006 -- 2016
Figure 5-36: Knee Reconstruction Synthetic Bone Graft Substitute Market, U.S., 2006 -- 2016
Figure 5-37: CMF Synthetic Bone Graft Substitute Market, U.S., 2006 -- 2016
Figure 5-38: Drivers and Limiters, Bone Graft Substitute Market, U.S., 2009
Figure 5-39: Leading Competitors, Bone Graft Substitute Market, U.S., 2009
Figure 5-40: Leading Competitors, Standard Allograft Market, U.S., 2009
Figure 5-41: Leading Competitors, DBM Market, U.S., 2009
Figure 5-42: Leading Competitors, Synthetic Bone Graft Substitute Market, U.S., 2009
MACHINED BONE ALLOGRAFT MARKET
Figure 6-1: ALIF Interbody Device Procedures by Material, U.S., 2006 -- 2016
Figure 6-2: PLIF Interbody Device Procedures by Material, U.S., 2006 -- 2016
Figure 6-3: TLIF Interbody Device Procedures by Material, U.S., 2006 -- 2016
Figure 6-4: Cervical Interbody Device Procedures by Material, U.S., 2006 -- 2016
Figure 6-5: Total Machined Bone Allograft Market, U.S., 2006 -- 2016
Figure 6-6: ALIF Machined Bone Allograft Procedures, U.S., 2006 -- 2016
Figure 6-7: ALIF Machined Bone Allograft Market, U.S., 2006 -- 2016
Figure 6-8: PLIF Machined Bone Allograft Procedures, U.S., 2006 -- 2016
Figure 6-9: PLIF Machined Bone Allograft Market, U.S., 2006 -- 2016
Figure 6-10: TLIF Machined Bone Allograft Procedures, U.S., 2006 -- 2016
Figure 6-11: TLIF Machined Bone Allograft Market, U.S., 2006 -- 2016
Figure 6-12: Cervical Machined Bone Allograft Procedures, U.S., 2006 -- 2016
Figure 6-13: Cervical Machined Bone Allograft Market, U.S., 2006 -- 2016
Figure 6-14: Drivers and Limiters, Machined Bone Allograft Market, U.S., 2009
Figure 6-15: Leading Competitors, Machined Bone Allograft Market, U.S., 2009
HYALURONIC ACID VISCOSUPPLEMENTATION MARKET
Figure 7-1: Hyaluronic Acid Viscosupplementation J-Codes, 2009
Figure 7-2: Total Viscosupplementation Market, U.S., 2006 -- 2016
Figure 7-3: Three-Injection Cycle Viscosupplementation Market, U.S., 2006 -- 2016
Figure 7-4: Five-Injection Cycle Hyaluronic Acid Viscosupplementation Market, U.S., 2006 -- 2016
Figure 7-5: Single-Injection Cycle Viscosupplementation Market, U.S., 2009 -- 2016
RESORBABLE FIXATION MARKET
Figure 8-1: Total Resorbable Fixation Market by Segment, U.S., 2006 -- 2016
Figure 8-2: Shoulder Resorbable Fixation Market, U.S., 2006 -- 2016
Figure 8-3: ACL/PCL Reconstruction Procedures, U.S., 2006 -- 2016
Figure 8-4: Total ACL/PCL Resorbable Fixation Market, U.S., 2006 -- 2016
Figure 8-5: Total ACL/PCL Resorbable Interference Screw Market by Material, U.S., 2006 -- 2016
Figure 8-6: Standard ACL/PCL Resorbable Interference Screw Market, U.S., 2006 -- 2016
Figure 8-7: Composite ACL/PCL Resorbable Interference Screw Market, U.S., 2006 -- 2016
Figure 8-8: Resorbable ACL/PCL Cross Pin Market, U.S., 2006 -- 2016
Figure 8-9: Meniscal Resorbable Fixation Market, U.S., 2006 -- 2016
Figure 8-10: Meniscal Tack Market, U.S., 2006 -- 2016
Figure 8-11: Hybrid Tack Market, U.S., 2006 -- 2016
Figure 8-12: Drivers and Limiters, Resorbable Fixation Market, U.S., 2009
Figure 8-13: Leading Competitors, Total Resorbable Fixation Market, U.S., 2009
TENDON GRAFT MARKET
Figure 9-1: ACL/PCL Reconstruction Procedures, U.S., 2006 -- 2016
Figure 9-2: Total Tendon Graft Market, U.S., 2006 -- 2016
Figure 9-3: Units Procured per Donor, U.S., 2009
Figure 9-4: Leading Competitors, Tendon Graft Market, U.S., 2009
CARTILAGE REPAIR MARKET
Figure 10-1: Cartilage Autograft Procedures, U.S., 2006 -- 2016
Figure 10-2: Total Cartilage Repair Market, U.S., 2006 -- 2016
Figure 10-3: Autologous Chondrocyte Implantation Market, U.S., 2006 -- 2016
Figure 10-4: Osteochondral Allograft Market, U.S., 2006 -- 2016
Figure 10-5: Meniscal Graft Market, U.S., 2006 -- 2016
Figure 10-6: Drivers and Limiters, Cartilage Repair Market, U.S., 2009
Figure 10-7: Leading Competitors, Cartilage Repair Market, U.S., 2009
PLATELET AND BONE MARROW CONCENTRATION MARKET
Figure 11-1: Total Platelet and Bone Marrow Concentration Market, U.S., 2006 -- 2016
Figure 11-2: Spinal Platelet Concentration Market, U.S., 2006 -- 2106
Figure 11-3: Extremity and Sports Medicine Platelet Concentration Market, U.S., 2006 -- 2016
Figure 11-4: Bone Marrow Aspirate Concentration Market, U.S., 2006 -- 2016
Figure 11-5: Drivers and Limiters, Platelet and Bone Marrow Concentration Market, U.S., 2009
Figure 11-6: Leading Competitors, Platelet and Bone Marrow Concentration Market, U.S., 2009
ORTHOPEDIC STEM CELL MARKET
Figure 12-1: Orthopedic Stem Cell Market, U.S., 2006 -- 2016
Figure 12-2: Lumbar Spine Stem Cell Market, U.S., 2006 -- 2016
Figure 12-3: Drivers and Limiters, Orthopedic Stem Cell Market, U.S., 2009
Figure 12-4: Leading Competitors, Orthopedic Stem Cell Market, U.S., 2009
EMERGING TECHNOLOGIES
ABBREVIATIONS

LIST OF CHARTS
EXECUTIVE SUMMARY
Chart 1-1: Total Orthopedic Biomaterials Market, U.S. 2009
Chart 1-2: Orthopedic Biomaterials Market by Segment, U.S., 2006 -- 2016
Chart 1-3: Machined Bone Allograft Market, U.S., 2006 -- 2016
Chart 1-4: Single-Injection Viscosupplementation Market, U.S., 2009 -- 2016
Chart 1-5: Resorbable Shoulder Fixation Device Market, U.S., 2006 -- 2016
Chart 1-6: Tendon Allograft Unit Volumes in Relation to ACL/PCL Procedures, U.S., 2006 -- 2016
Chart 1-7: Cartilage Autograft Procedure Volumes, U.S., 2006 -- 2016
Chart 1-8: Platelet and Bone Marrow Concentration Market for Orthopedic Indications, U.S., 2007 -- 2016
Chart 1-9: Orthopedic Stem Cell Market, U.S., 2006-- 2016
Chart 1-10: Leading Competitors, Orthopedic Biomaterials Market, U.S., 2009
RESEARCH METHODOLOGY
OVERVIEW OF ORTHOPEDIC BIOMATERIALS
Chart 3-1: Total Orthopedic Biomaterials Market, U.S., 2006 -- 2016
Chart 3-2: Total Orthopedic Biomaterials Market by Segment, U.S., 2006 -- 2016
Chart 3-3: Total Orthopedic Biomaterials Market by Segment, U.S., 2009
Chart 3-4: Total Orthopedic Biomaterials Market by Segment, U.S., 2016
Chart 3-5: Leading Competitors, Orthopedic Biomaterials Market, U.S., 2009
Chart 3-6: Market Concentration, Orthopedic Biomaterials Market, U.S., 2009
GROWTH FACTOR MARKET
Chart 4-1: Total Growth Factor Market, U.S., 2006 -- 2016
Chart 4-2: Leading Competitors, Growth Factor Market, U.S., 2009
BONE GRAFT SUBSTITUTE MARKET
Chart 5-1: Total Bone Graft Substitute Market, U.S., 2006 -- 2016
Chart 5-2: Cervical Spinal Bone Graft Substitute Market, U.S., 2006 -- 2016
Chart 5-3: Trauma Bone Graft Substitute Market, U.S., 2006 -- 2016
Chart 5-4: Hip Bone Graft Substitute Market, U.S., 2006 -- 2016
Chart 5-5: Knee Bone Graft Substitute Market, U.S., 2006 -- 2016
Chart 5-6: CMF Bone Graft Substitute Market, U.S., 2006 -- 2016
Chart 5-7: Total Standard Allograft Market, U.S., 2006 -- 2016
Chart 5-8: Spinal Standard Allograft Market, U.S., 2006 -- 2016
Chart 5-9: Thoracolumbar Spinal Standard Allograft Market, U.S., 2006 -- 2016
Chart 5-10: Cervical Spinal Standard Allograft Market, U.S., 2006 -- 2016
Chart 5-11: Trauma, Reconstruction and CMF Standard Allograft Procedures, U.S., 2009
Chart 5-12: Trauma, Reconstruction and CMF Standard Allograft Market, U.S., 2006 -- 2016
Chart 5-13: Total DBM Market, U.S., 2006 -- 2016
Chart 5-14: Spinal DBM Market, U.S., 2006 -- 2016
Chart 5-15: Thoracolumbar Spinal DBM Market, U.S., 2006 -- 2016
Chart 5-16: Cervical Spinal DBM Market, U.S., 2006 -- 2016
Chart 5-17: Trauma, Reconstruction and CMF DBM Procedures, U.S., 2009
Chart 5-18: Trauma, Reconstruction and CMF DBM Market, U.S., 2006 -- 2016
Chart 5-19: Total Synthetic Bone Graft Substitute Market, U.S., 2006 -- 2016
Chart 5-20: Spinal Synthetic Bone Graft Substitute Market, U.S., 2006 -- 2016
Chart 5-21: Thoracolumbar Spinal Synthetic Bone Graft Substitute Market, U.S., 2006 -- 2016
Chart 5-22: Cervical Spinal Synthetic Bone Graft Market, U.S., 2006 -- 2016
Chart 5-23: Trauma, Reconstruction and CMF Synthetic Bone Graft Substitute Procedures, U.S., 2009
Chart 5-24: Trauma, Reconstruction and CMF Synthetic Bone Graft Substitute Market, U.S., 2006 -- 2016
Chart 5-25: Leading Competitors, Bone Graft Substitute Market, U.S., 2009
Chart 5-26: Leading Competitors, Standard Allograft Market, U.S., 2009
Chart 5-27: Leading Competitors, DBM Market, U.S., 2009
Chart 5-28: Leading Competitors, Synthetic Bone Graft Substitute Market, U.S., 2009
MACHINED BONE ALLOGRAFT MARKET
Chart 6-1: Total Machined Bone Allograft Market, U.S., 2006 -- 2016
Chart 6-2: ALIF Machined Bone Allograft Market, U.S., 2006 -- 2016
Chart 6-3: PLIF Machined Bone Allograft Market, U.S., 2006 -- 2016
Chart 6-4: TLIF Machined Bone Allograft Market, U.S., 2006 -- 2016
Chart 6-5: Cervical Machined Bone Allograft Market, U.S., 2006 -- 2016
Chart 6-6: Leading Competitors, Machined Bone Allograft Market, U.S., 2009
HYALURONIC ACID VISCOSUPPLEMENTATION MARKET
Chart 7-1: Total Viscosupplementation Market, U.S., 2006 -- 2016
Chart 7-2: Three-Injection Cycle Viscosupplementation Market, U.S., 2006 -- 2016
Chart 7-3: Five-Injection Cycle Viscosupplementation Market, U.S., 2006 -- 2016
Chart 7-4: Single-Injection Cycle Viscosupplementation Market, U.S., 2009 -- 2016
RESORBABLE FIXATION MARKET
Chart 8-1: Total Resorbable Fixation Market, U.S., 2006 -- 2016
Chart 8-2: Total Resorbable Fixation Market by Segment, U.S., 2006 -- 2016
Chart 8-3: Shoulder Resorbable Fixation Market, U.S., 2006 -- 2016
Chart 8-4: Total ACL/PCL Resorbable Interference Screw Market by Material, U.S., 2006 -- 2016
Chart 8-5: Standard ACL/PCL Resorbable Interference Screw Market, U.S., 2006 -- 2016
Chart 8-6: Composite ACL/PCL Resorbable Interference Screw Market, U.S., 2006 -- 2016
Chart 8-7: Resorbable ACL/PCL Cross Pin Market, U.S., 2006 -- 2016
Chart 8-8: Meniscal Resorbable Fixation Market, U.S., 2006 -- 2016
Chart 8-9: Meniscal Tack Market, U.S., 2006 -- 2016
Chart 8-10: Hybrid Tack Market, U.S., 2006 -- 2016
Chart 8-11: Leading Competitors, Total Resorbable Fixation Market, U.S., 2009
TENDON GRAFT MARKET
Chart 9-1: Total Tendon Graft Market, U.S., 2006 -- 2016
Chart 9-2: Units Procured per Donor, U.S., 2009
Chart 9-3: Leading Competitors, Tendon Graft Market, U.S., 2009
CARTILAGE REPAIR MARKET
Chart 10-1: Total Cartilage Repair Market, U.S., 2006 -- 2016
Chart 10-2: Autologous Chondrocyte Implantation Market, U.S., 2006 -- 2016
Chart 10-3: Osteochondral Allograft Market, U.S., 2006 -- 2016
Chart 10-4: Meniscal Graft Market, U.S., 2006 -- 2016
Chart 10-5: Leading Competitors, Total Cartilage Repair Market, U.S., 2009
PLATELET AND BONE MARROW CONCENTRATION MARKET
Chart 11-1: Total Platelet and Bone Marrow Concentration Market, U.S., 2006 -- 2016
Chart 11-2: Spinal Platelet Concentration Market, U.S., 2006 -- 2016
Chart 11-3: Extremity and Sports Medicine Platelet Concentration Market, U.S., 2006 -- 2016
Chart 11-4: Bone Marrow Aspirate Concentration, U.S., 2006 -- 2106
Chart 11-5: Leading Competitors, Platelet and Bone Marrow Concentration Market, U.S., 2009
ORTHOPEDIC STEM CELL MARKET
Chart 12-1: Orthopedic Stem Cell Market, U.S., 2006 -- 2016
Chart 12-2: Lumbar Spine Stem Cell Market, U.S., 2006 -- 2016
Chart 12-3: Cervical Spine Stem Cell Market, U.S., 2006 -- 2016
Chart 12-4: Leading Competitors, Orthopedic Stem Cell Market, U.S., 2009
EMERGING TECHNOLOGIES
ABBREVIATIONS